Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Sales $ 273,135 $ 262,979 $ 1,304,967 $ 993,934
Cost of sales (326,035) (535,944) (1,364,635) (1,275,191)
Gross loss (52,900) (272,965) (59,668) (281,257)
Operating Expenses        
Selling and marketing 95,664 2,347 303,414 85,225
General and administrative 1,563,251 1,437,750 4,980,668 4,816,105
Depreciation and amortization 57,100 11,274 122,072 63,347
Total operating expenses 1,716,015 1,451,371 5,406,154 4,964,677
Loss from Operations (1,768,915) (1,724,336) (5,465,822) (5,245,934)
Other (Income) Expenses        
Interest expense, net 104,134 53,141 239,467 144,075
Gain on sale of investment in subsidiary (199,200)
Common stock price modification 941,530
Warrant modification expenses 68,548
Total other expenses 104,134 53,141 40,267 1,154,153
Loss from Continuing Operations (1,873,049) (1,777,477) (5,506,089) (6,400,087)
Loss from Discontinued Operations (369,225) (106,543) (1,037,549)
Net Loss (1,873,049) (2,146,702) (5,612,632) (7,437,636)
Dividends paid to Series B preferred stockholders (60,515) (60,515)
Deemed dividend to Series B preferred stockholders (124,681) (124,681)
Net loss attributable to common stockholders $ (2,058,245) $ (2,146,702) $ (5,797,828) $ (7,437,636)
Net loss per basic and diluted common share:        
Loss from continuing operations $ (0.04) $ (0.04) $ (0.13) $ (0.16)
Loss from discontinued operations (0.01) (0.02)
Net loss per common share $ (0.04) $ (0.05) $ (0.13) $ (0.18)
Weighted Average Number of Common Shares Outstanding        
Basic and Diluted 43,036,406 41,708,005 42,982,321 40,597,215